James Aloysius Brady insider trades

Open-market stock purchases and sales by James Aloysius Brady, Director at Xeris Biopharma Holdings, Inc, from SEC Form 4 filings since Mar 14, 2022.

Recent trades

DateStockTradeValue
Jun 4, 2026XERS Xeris Biopharma Holdings, IncBought (not open market)—
Jun 4, 2026XERS Xeris Biopharma Holdings, IncBought (not open market)$203K
Mar 30, 2026XERS Xeris Biopharma Holdings, IncSold$60K

Companies traded

  • XERS Xeris Biopharma Holdings, Inc: 1 sale, last Jun 4, 2026
  • VRNA Verona Pharma plc: 1 sale, last Oct 7, 2025

Get free alerts when James Aloysius Brady files a new trade →